Futibatinib in Patients Previously Enrolled in an Antecedent Futibatinib as Monotherapy or Combination Therapy.
Clinical trial NCT06506955 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06506955
- Sponsor
- Taiho Oncology, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-01
- Primary completion
- 2027-04-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.